ALLERGAN IS UNCUT GEM IN SMITHKLINE BEECHAM MERGER; SPIN-OFF GUARANTEES SHAREHOLDER VALUE -- FIRM IS CANDIDATE FOR LEVERAGED BUYOUT, PURCHASE OFFERS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".